BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10728463)

  • 1. Current and novel agents for the treatment of cytomegalovirus retinitis.
    Akerele T; Lightman S
    Drugs R D; 1999 Nov; 2(5):289-97. PubMed ID: 10728463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis.
    Turner N; Strand A; Grewal DS; Cox G; Arif S; Baker AW; Maziarz EK; Saullo JH; Wolfe CR
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR; Jabs DA
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
    Wohl DA; Kendall MA; Owens S; Holland G; Nokta M; Spector SA; Schrier R; Fiscus S; Davis M; Jacobson MA; Currier JS; Squires K; Alston-Smith B; Andersen J; Freeman WR; Higgins M; Torriani FJ;
    HIV Clin Trials; 2005; 6(3):136-46. PubMed ID: 16192248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus Retinitis: A Review.
    Port AD; Orlin A; Kiss S; Patel S; D'Amico DJ; Gupta MP
    J Ocul Pharmacol Ther; 2017 May; 33(4):224-234. PubMed ID: 28355091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents.
    Vadlapudi AD; Vadlapatla RK; Mitra AK
    Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):8-18. PubMed ID: 22044356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drugs for treating CMV. Valcyte, an oral compound, expands the treatment options for people with CMV retinitis.
    Eagan L
    Posit Living; 2001; 10(6):13. PubMed ID: 11702748
    [No Abstract]   [Full Text] [Related]  

  • 8. New drug for CMV retinitis.
    AIDS Patient Care; 1995 Oct; 9(5):256. PubMed ID: 11361411
    [No Abstract]   [Full Text] [Related]  

  • 9. Ganciclovir resistance: a matter of time and titre.
    Drew WL
    Lancet; 2000 Aug; 356(9230):609-10. PubMed ID: 10968428
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive retinitis-encephalitis due to ganciclovir-resistant cytomegalovirus associated with aplastic anemia.
    Sasaki T; Okayama A; Eizuru Y; Murai K; Matsuoka H; Uno H; Minamishima Y; Kataoka H; Koono M; Matsuura Y; Nao-i N; Sawada A; Tachibana N; Tsubouchi H
    Intern Med; 1997 May; 36(5):375-9. PubMed ID: 9213178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
    Kuo IC; Kempen JH; Dunn JP; Vogelsang G; Jabs DA
    Am J Ophthalmol; 2004 Sep; 138(3):338-46. PubMed ID: 15364214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing therapeutic paradigms in CMV retinitis in AIDS.
    Piper H; Ciulla TA; Danis RP; Pratt LM
    Expert Opin Pharmacother; 2000 Dec; 1(7):1343-52. PubMed ID: 11249469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
    Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
    J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
    Levi ME; Mandava N; Chan LK; Weinberg A; Olson JL
    Transpl Infect Dis; 2006 Mar; 8(1):38-43. PubMed ID: 16623819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sevirumab. Protovir, MSL 109, EV2 7, SDZ MSL 109.
    Drugs R D; 1999 Nov; 2(5):315-7. PubMed ID: 10728470
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of ganciclovir-resistant cytomegalovirus retinitis in HIV infection in the era of antiretroviral therapy.
    Adler H; De Gascun CF; McSweeney F; Acheson RW; Brannigan ET; Duffy M; Keegan DJ; Lambert JS
    Int J STD AIDS; 2014 Oct; 25(11):827-9. PubMed ID: 24516078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMV drug shows promise.
    AIDS Patient Care; 1995 Oct; 9(5):258-9. PubMed ID: 11361418
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical course of cytomegalovirus retinitis with the different antiretroviral therapies in our hospital].
    Moreno Ruiz O; Ferrer Novella E; Torrón Fernández C; Arazo Garcés P; Melcon Sánchez B; Honrubia López FM
    Arch Soc Esp Oftalmol; 2001 Jul; 76(7):397-402. PubMed ID: 11438875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update (1995) on clinical trials of antiviral therapy and prophylaxis for AIDS-related cytomegalovirus disease.
    Jacobson MA
    Scand J Infect Dis Suppl; 1995; 99():96-9. PubMed ID: 8668951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.